Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy
暂无分享,去创建一个
F. Yin | Z. Chang | Chunhao Wang | J. Horton
[1] Jorge J. Moré,et al. The Levenberg-Marquardt algo-rithm: Implementation and theory , 1977 .
[2] P. Grenier,et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.
[3] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[4] L. Tabár,et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] James S. Duncan,et al. Rigid point feature registration using mutual information , 1999, Medical Image Anal..
[6] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[7] W. Rooney,et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange , 2000, Magnetic resonance in medicine.
[8] E Marubini,et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] R. Hoffmann,et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. , 2001, Journal of the National Cancer Institute.
[10] Risto A Kauppinen,et al. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.
[11] A. Padhani. MRI for assessing antivascular cancer treatments. , 2003, The British journal of radiology.
[12] Kenya Murase,et al. Efficient method for calculating kinetic parameters using T1‐weighted dynamic contrast‐enhanced magnetic resonance imaging , 2004, Magnetic resonance in medicine.
[13] Daniele Regge,et al. Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging , 2004, Breast Cancer Research and Treatment.
[14] D. Roses,et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. , 2004, International journal of radiation oncology, biology, physics.
[15] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[16] A. Padhani,et al. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging , 2005, Abdominal Imaging.
[17] Yael Paran,et al. Water diffusion in the different microenvironments of breast cancer , 2004, NMR in biomedicine.
[18] Robert D Timmerman,et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. , 2005, International journal of radiation oncology, biology, physics.
[19] T. Major,et al. Brachytherapy for partial breast irradiation: the European experience. , 2005, Seminars in radiation oncology.
[20] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[21] F. Vicini,et al. Accelerated partial breast irradiation as a part of breast conservation therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] John Suckling,et al. Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[23] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[24] M. Giger,et al. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. , 2006, Medical physics.
[25] H. Geinitz,et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) , 2006, Acta oncologica.
[26] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Hai-Ling Margaret Cheng,et al. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1‐weighted DCE‐MRI , 2007, Journal of magnetic resonance imaging : JMRI.
[28] Peter Boesiger,et al. Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast‐enhanced abdominal MRI , 2007, Magnetic resonance in medicine.
[29] M. Schell,et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.
[30] M. Bastin,et al. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. , 2007, Magnetic resonance imaging.
[31] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[32] Bernd Hamm,et al. Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas , 2008, Journal of magnetic resonance imaging : JMRI.
[33] L. Price,et al. Toxicity of 3D-CRT for Accelerated Partial Breast Irradiation , 2008 .
[34] P. Hermann,et al. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. , 2008, Dalton transactions.
[35] L. Price,et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. , 2009, International journal of radiation oncology, biology, physics.
[36] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[37] Vlayka Liotcheva,et al. DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[38] T. B. Pedersen,et al. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE‐MRI, ex vivo HR MAS, and in vivo 1H MRS , 2010, NMR in biomedicine.
[39] Qiang He,et al. Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory. , 2010, Medical physics.
[40] R. Jagsi,et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. , 2010, International journal of radiation oncology, biology, physics.
[41] Jong Hyo Kim,et al. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI. , 2010, Medical physics.
[42] Cedric X. Yu,et al. Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future. , 2010, International journal of radiation oncology, biology, physics.
[43] T W Redpath,et al. The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T , 2010, Physics in medicine and biology.
[44] N. deSouza,et al. Functional magnetic resonance: biomarkers of response in breast cancer , 2011, Breast Cancer Research.
[45] Xia Li,et al. Robustness of Quantitative Compressive Sensing MRI: The Effect of Random Undersampling Patterns on Derived Parameters for DCE- and DSC-MRI , 2012, IEEE Transactions on Medical Imaging.
[46] R. Blitzblau,et al. Use of Adjuvant Radiation Therapy in Elderly Patients With Early Stage Breast Cancer: Changes in Practice Patterns After Publication of Cancer and Leukemia Group B (CALGB) 9343 , 2012 .
[47] A. Jackson,et al. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.
[48] Fang-Fang Yin,et al. Review of treatment assessment using DCE-MRI in breast cancer radiation therapy. , 2014, World journal of methodology.